Nara Pravat, DO
Pain Medicine · Plano, TXNPI 1396906673
Payments from drug & device makers
Across 73 payments — averaging $18.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$458
- Scilex Pharmaceuticals Inc.$272
- Pfizer$159
- Kowa Pharmaceuticals America, Inc.$89
- Biodelivery Sciences International, Inc.$71
- Lundbeck LLC$64
- plus $261 from 10 others
What the payments were for
- Food & beverage$1,375100%
- Gifts$00%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 24 | $458 |
| Scilex Pharmaceuticals Inc. | 14 | $272 |
| Pfizer | 9 | $159 |
| Kowa Pharmaceuticals America, Inc. | 6 | $89 |
| Biodelivery Sciences International, Inc. | 4 | $71 |
| Lundbeck LLC | 3 | $64 |
| MDD US Operations, LLC | 3 | $53 |
| Ossur Americas, Inc. | 2 | $35 |
| Pacira Therapeutics, Inc. | 1 | $27 |
| Vertex | 1 | $26 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $25 |
| Amgen | 1 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Baudax Bio Inc. | 1 | $17 |
| Abbott | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
How this compares
$1,375 in reported general payments places this provider in the 30th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 509 | $18,991 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 141 | $7,849 |
| Lidocaine | 36 | $5,144 |
| Fentanyl | 33 | $3,984 |
| Oxycodone Hcl | 144 | $3,389 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 19 | $1,623 |
| Gabapentin | 142 | $1,605 |
| Morphine Sulfate ErMorphine Sulfate | 45 | $1,354 |
| Pregabalin | 76 | $1,252 |
| Hydromorphone Hcl | 55 | $1,209 |
| Eletriptan HbrEletriptan Hydrobromide | 13 | $1,118 |
| Sumatriptan | 12 | $1,069 |
| Tramadol Hcl ErTramadol Hcl | 14 | $976 |
| Cyclobenzaprine Hcl | 91 | $916 |
| Celecoxib | 36 | $821 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Plano
- Noor GajrajPlano$85K
- Jonathan KoningPlano$47K
- Aaron CalodneyTyler$3M
- Mitchell EngleHouston$1.5M
- Melissa MurphyGrapevine$711K
- Shiraz YazdaniLubbock$632K
- Muhammad ZulqarnainDallas$556K
- Daniel PakHouston$460K
- Marvin ChangSugar Land$306K
- David LeimanHouston$281K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.